Skip to Main Content

News Center

Drug Development

AAPS/DDDI Meeting Brings Drug Design and Discovery Experts to the School

September 18, 2017

Event spotlights cutting-edge pharmaceutical sciences research being conducted across the region and offers networking opportunities for attendees.

SOP, UCSF Partner for New Initiative on Pediatric Drug and Device Development

September 11, 2017

Partnership will facilitate the development of therapeutics for pediatric patients and provide research and education opportunities for faculty, students, and trainees.

A Metabolic Pathway that Feeds Liver Cancer

August 23, 2017

Research published by Hongbing Wang, PhD, professor in the Department of Pharmaceutical Sciences (PSC), may explain how some liver cancer cells obtain the nutrition they need to proliferate.

CERSI Symposium Highlights Use of Biomarkers in Drug Development

August 28, 2015

More than 500 researchers from academia, government, and industry gather to gain perspective on biomarker development and the application of biomarkers in preclinical and clinical research.

CERSI Conference Spotlights New Applications for Top-Down Mass Spectrometry

June 30, 2014

Researchers from academia, government, and industry examine benefits and new methods associated with emerging technology.

SOP Hosts Third International Conference on Microneedles

June 11, 2014

Event brings together researchers from academia, industry, and government to network and share the latest developments in microneedle technology and applications.

CERSI Conference Spotlights Need for Mass Spectrometry in Drug Development

April 16, 2014

Researchers from academia, government, and industry examine current challenges surrounding mass spectrometry as a drug development tool, including its status of adoption by industry and potential regulatory implications.